Display options
Share it on

Front Cell Neurosci. 2018 Jul 12;12:202. doi: 10.3389/fncel.2018.00202. eCollection 2018.

Frontotemporal Dementia-Associated N279K Tau Mutation Localizes at the Nuclear Compartment.

Frontiers in cellular neuroscience

Maxi L Ritter, Jesús Avila, Vega García-Escudero, Félix Hernández, Mar Pérez

Affiliations

  1. Departamento de Anatomía Histología y Neurociencia, Facultad de Medicina, Universidad Autonoma de Madrid (UAM), Madrid, Spain.
  2. Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autonoma de Madrid (UAM), Madrid, Spain.
  3. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Carlos III Institute of Health, Madrid, Spain.

PMID: 30050413 PMCID: PMC6052045 DOI: 10.3389/fncel.2018.00202

Abstract

Tau is a microtubule-associated protein that plays an important role in Alzheimer's disease and related tauopathies. Approximately one-half of all cases of Frontotemporal dementia with parkinsonism-17 (FTDP-17) are caused by mutations in the MAPT gene. The N279K mutation is one of the three mutations more prevalent in FTDP-17 cases. Several studies have demonstrated that N279K Tau mutation alters alternative splicing inducing the presence of exon 10. Tau is mainly found in the cytosol of neuronal cells although it has also been localized within the nucleus. Here we demonstrate by biochemical and immunohistochemistry studies in COS-7 cells, that the proportion of mutant N279K Tau increases compared with wild-type at the cell nucleus although cell viability is not affected. These data will provide us with a better outline of the nuclear role of tau protein offering new clues related with this tauopathie.

Keywords: Alzheimer; FTDP-17; nucleus; tau; transport

References

  1. Physiol Rev. 2004 Apr;84(2):361-84 - PubMed
  2. Mol Neurodegener. 2015 Sep 15;10:46 - PubMed
  3. Science. 2016 Jan 8;351(6269):173-6 - PubMed
  4. Biochim Biophys Acta. 2005 Jan 3;1739(2-3):179-97 - PubMed
  5. EMBO J. 1989 Feb;8(2):393-9 - PubMed
  6. Biochem Biophys Res Commun. 1986 Dec 15;141(2):790-6 - PubMed
  7. Mol Cell Biochem. 1994 Jan 26;130(2):187-96 - PubMed
  8. Biomolecules. 2016 Jan 07;6(1):9 - PubMed
  9. J Neurosci. 2007 Aug 22;27(34):9155-68 - PubMed
  10. Science. 1998 Dec 4;282(5395):1914-7 - PubMed
  11. Mol Biol Cell. 2014 Nov 5;25(22):3541-51 - PubMed
  12. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8422-6 - PubMed
  13. J Biol Chem. 2018 May 25;293(21):8065-8076 - PubMed
  14. Acta Neuropathol Commun. 2013 Aug 21;1:54 - PubMed
  15. Acta Neuropathol. 1999 Jul;98(1):62-77 - PubMed
  16. J Cell Sci. 2006 May 15;119(Pt 10):2025-34 - PubMed
  17. PLoS One. 2014 Aug 15;9(8):e104690 - PubMed
  18. PLoS One. 2013 Dec 30;8(12):e84849 - PubMed
  19. Hippocampus. 2007;17(2):98-102 - PubMed
  20. Neurochem Res. 2000 Jan;25(1):43-50 - PubMed
  21. Protein Eng Des Sel. 2004 Jun;17(6):527-36 - PubMed
  22. Cell Cycle. 2008 Jun 15;7(12):1788-94 - PubMed
  23. Neurology. 2001 Jun;56(11 Suppl 4):S21-5 - PubMed
  24. J Cell Biol. 1995 Dec;131(5):1327-40 - PubMed
  25. Cell. 1981 Jan;23(1):175-82 - PubMed
  26. Biochemistry. 2000 Sep 26;39(38):11714-21 - PubMed
  27. Exp Cell Res. 1998 Aug 1;242(2):540-7 - PubMed
  28. Brain Res Mol Brain Res. 1996 Jul;39(1-2):79-88 - PubMed

Publication Types